Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms [pdf]

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by CardenB on Saturday October 14, 2017 @01:39AM (#15470953)

“Life time use” and “one time use triggering latent psychological conditions” are very different. Of course those who use over a long period of time aren’t showing adverse conditions. The ones who were triggered stayed away.

[ Parent | on HN ]

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by amelius on Saturday October 14, 2017 @09:12AM (#15472003)

From the linked article:

> Of those, 14% described themselves as having used at any point in their lives any of the three ‘classic’ psychedelics: LSD, psilocybin (the active ingredient in so-called magic mushrooms) and mescaline (found in the peyote and San Pedro cacti). The researchers found that individuals in this group were not at increased risk of developing 11 indicators of mental-health problems such as schizophrenia, psychosis, depression, anxiety disorders and suicide attempts.

Emphasis on "at any point in their lives".

[ Parent | on HN ]

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by mulvya on Saturday October 14, 2017 @02:33AM (#15471056)

“Life time use” != "use over a long period of time"

In epidemiological surveys, lifetime use == reports using at least once.

[ Parent | on HN ]

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by Alex3917 on Saturday October 14, 2017 @02:42PM (#15473541)

> In epidemiological surveys, lifetime use == reports using at least once.

Not necessarily. For smoking you need to smoke 100 cigarettes before qualifying for lifetime use.

[ Parent | on HN ]

Re:Psilocybin for treatment-resistant depression: fMRI-measu... by clappski on Sunday October 15, 2017 @04:16AM (#15476342)

100 cigarettes seems like a very low threshold, that’s 5 packs of 20, even moderate smokers (>10 per day) could go through 200 in a month.

[ Parent | on HN ]